MaxCyte, Inc. (MXCT) NASDAQ
0.75
+0.0055(+0.74%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.75
+0.0055(+0.74%)
Currency In USD
Address
9713 Key West Avenue
Rockville, MD 20850
United States of America (the)
Phone
301 944 1700
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
114
First IPO Date
July 30, 2021
| Name | Title | Pay | Year Born |
| Maher Masoud | President, Chief Executive Officer & Executive Director | 990,004 | 1975 |
| Douglas J. Swirsky | Chief Financial Officer | 700,557 | 1969 |
| Jack Horgan | Senior Vice President of Corporate Development | 0 | N/A |
| Jay Gelfman | Senior Vice President of Operations | 0 | N/A |
| Ana-Paula Martins Fernandes | Senior Vice President of Global Sales | 0 | N/A |
| Jill Mayer | Senior Vice President of Human Resources | 0 | N/A |
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.